REVB Revelation Biosciences Inc

Price (delayed)

$1.58

Market cap

$2.58M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$35.99

Enterprise value

-$11.97M

Highlights
The quick ratio is up by 29% since the previous quarter and by 27% year-on-year
REVB's equity is up by 43% since the previous quarter but it is down by 5% year-on-year
The EPS has dropped by 112% year-on-year

Key stats

What are the main financial stats of REVB
Market
Shares outstanding
1.63M
Market cap
$2.58M
Enterprise value
-$11.97M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.27
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$8.96M
EBITDA
-$8.94M
Free cash flow
-$8.57M
Per share
EPS
-$35.99
Free cash flow per share
-$7.86
Book value per share
$5.8
Revenue per share
$0
TBVPS
$13.49
Balance sheet
Total assets
$14.7M
Total liabilities
$5.23M
Debt
$0
Equity
$9.47M
Working capital
$9.4M
Liquidity
Debt to equity
0
Current ratio
2.8
Quick ratio
2.78
Net debt/EBITDA
1.63
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-62.7%
Return on equity
-98.6%
Return on invested capital
N/A
Return on capital employed
-94.6%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

REVB stock price

How has the Revelation Biosciences stock price performed over time
Intraday
-2.47%
1 week
-15.05%
1 month
-25.12%
1 year
-93.42%
YTD
-89.48%
QTD
-16.84%

Financial performance

How have Revelation Biosciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$8.94M
Net income
-$8.96M
Gross margin
N/A
Net margin
N/A
REVB's operating income has plunged by 52% YoY and by 3.3% from the previous quarter

Growth

What is Revelation Biosciences's growth rate over time

Valuation

What is Revelation Biosciences stock price valuation
P/E
N/A
P/B
0.27
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has dropped by 112% year-on-year
The price to book (P/B) is 44% lower than the last 4 quarters average of 0.5
REVB's equity is up by 43% since the previous quarter but it is down by 5% year-on-year

Efficiency

How efficient is Revelation Biosciences business performance

Dividends

What is REVB's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for REVB.

Financial health

How did Revelation Biosciences financials performed over time
The company's total assets is 181% higher than its total liabilities
Revelation Biosciences's total liabilities has decreased by 35% YoY and by 6% from the previous quarter
The quick ratio is up by 29% since the previous quarter and by 27% year-on-year
The debt is 100% less than the equity
REVB's equity is up by 43% since the previous quarter but it is down by 5% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.